Aya Naiki‐Ito
Papers
1
Total Citations
4
H-Index
1
About
Dr. Aya Naiki-Ito is a leading researcher in prostate cancer chemoprevention and urologic oncology, with a focus on natural compounds and their clinical applications. Her most notable contribution involves investigating luteolin, a dietary flavonoid, as a potential therapeutic agent for prostate cancer. In her landmark 2025 study, she provided the first preliminary evidence on the safety and clinical efficacy of luteolin for patients with prostate cancer under active surveillance, addressing the critical need for effective, non-toxic interventions to prevent disease progression. This work builds on her earlier preclinical research demonstrating luteolin's chemopreventive and chemotherapeutic potential. With over 4 citations already for this recent publication, Dr. Naiki-Ito's research bridges the gap between laboratory findings and clinical practice, offering hope for managing prostate cancer recurrence after androgen deprivation therapy. Her contributions are particularly significant given the growing interest in lifestyle-based cancer prevention strategies, positioning her as a key figure in the development of natural compound-based therapies for urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1